Sodium in PDB 7ke1: Factor H Enhancing Human Antibody Fragment (Fab) to Meningococcal Factor H Binding Protein

The structure of Factor H Enhancing Human Antibody Fragment (Fab) to Meningococcal Factor H Binding Protein, PDB code: 7ke1 was solved by P.T.Beernink, N.Sands, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	70.47 / 1.50
Space group	P 1 21 1
Cell size a, b, c (Å), α, β, γ (°)	67.771, 97.26, 70.472, 90, 90.37, 90
R / Rfree (%)	16.2 / 18.3

The structure of Factor H Enhancing Human Antibody Fragment (Fab) to Meningococcal Factor H Binding Protein also contains other interesting chemical elements:

Chlorine

(Cl)

1 atom

The binding sites of Sodium atom in the Factor H Enhancing Human Antibody Fragment (Fab) to Meningococcal Factor H Binding Protein (pdb code 7ke1). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Factor H Enhancing Human Antibody Fragment (Fab) to Meningococcal Factor H Binding Protein, PDB code: 7ke1:

Sodium binding site 1 out of 1 in the Factor H Enhancing Human Antibody Fragment (Fab) to Meningococcal Factor H Binding Protein


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Factor H Enhancing Human Antibody Fragment (Fab) to Meningococcal Factor H Binding Protein within 5.0Å range: probe atom residue distance (Å) B Occ B:Na304 b:31.7 occ:1.00 HG23 B:THR199 2.6 31.0 0.1 OG1 B:THR199 2.8 24.4 0.9 O B:GLU197 2.9 17.4 1.0 H B:THR199 2.9 21.9 0.1 H B:THR199 2.9 21.9 0.9 HG1 B:THR199 3.0 29.2 0.9 HG2 B:LYS147 3.1 47.9 1.0 HG22 B:THR199 3.2 31.0 0.1 HB3 B:LYS147 3.2 33.8 1.0 HD3 B:LYS147 3.3 65.0 1.0 CG2 B:THR199 3.3 25.8 0.1 N B:THR199 3.3 18.3 1.0 OE1 B:GLU197 3.3 43.9 1.0 HB3 B:GLN149 3.5 24.7 1.0 HA B:VAL198 3.5 21.3 1.0 O B:LYS147 3.5 23.2 1.0 C B:GLU197 3.5 15.7 1.0 HB B:THR199 3.5 27.1 0.9 H B:GLN149 3.6 18.9 1.0 HB2 B:GLN149 3.7 24.7 1.0 CB B:THR199 3.7 22.6 0.9 OG1 B:THR199 3.7 22.2 0.1 HB3 B:GLU197 3.7 28.4 1.0 CG B:LYS147 3.7 40.0 1.0 C B:VAL198 3.7 17.1 1.0 CB B:THR199 3.8 22.9 0.1 CD B:LYS147 3.9 54.2 1.0 CA B:VAL198 3.9 17.8 1.0 HG1 B:THR199 3.9 26.6 0.1 CB B:LYS147 3.9 28.2 1.0 N B:VAL198 3.9 18.8 1.0 C B:LYS147 4.0 21.0 1.0 HE2 B:LYS147 4.0 71.4 1.0 N B:GLN149 4.0 15.8 1.0 CB B:GLN149 4.0 20.6 1.0 HG2 B:GLU197 4.0 36.7 1.0 HA B:VAL148 4.0 20.9 1.0 HG21 B:THR199 4.1 31.0 0.1 CA B:THR199 4.1 21.0 0.9 CA B:THR199 4.1 21.1 0.1 HB3 B:PRO206 4.2 35.4 1.0 CD B:GLU197 4.2 42.8 1.0 CB B:GLU197 4.4 23.6 1.0 CG B:GLU197 4.4 30.6 1.0 O B:HOH536 4.4 39.8 1.0 CE B:LYS147 4.5 59.5 1.0 C B:VAL148 4.5 15.4 1.0 N B:VAL148 4.5 20.1 1.0 O B:VAL198 4.5 18.9 1.0 CA B:VAL148 4.6 17.4 1.0 CA B:GLU197 4.6 16.8 1.0 H B:VAL198 4.6 22.5 1.0 HA B:THR199 4.6 25.2 0.9 CA B:LYS147 4.6 21.4 1.0 HG3 B:LYS147 4.6 47.9 1.0 HA B:THR199 4.7 25.3 0.1 CA B:GLN149 4.7 17.4 1.0 HB2 B:LYS147 4.7 33.8 1.0 HD2 B:LYS147 4.7 65.0 1.0 HB B:THR199 4.8 27.4 0.1 HZ3 B:LYS147 4.8 83.0 1.0

N.Sands, P.T.Beernink. Structural Mechanisms For Enhancement of A Complement Regulator By Vaccine-Elicited Human Antibodies To Be Published.